Nivolumab Monotherapy for First-Line Treatment of Advanced Non-Small-Cell Lung Cancer von Gettinger, Scott, Rizvi, Naiyer A, Chow, Laura Q, Borghaei, Hossein, Brahmer, Julie, Ready, Neal, Gerber, David E, Shepherd, Frances A, Antonia, Scott, Goldman, Jonathan W, Juergens, Rosalyn A, Laurie, Scott A, Nathan, Faith E, Shen, Yun, Harbison, Christopher T, Hellmann, Matthew D

Volltext

Genetic Basis for Clinical Response to CTLA-4 Blockade in Melanoma von Snyder, Alexandra, Makarov, Vladimir, Merghoub, Taha, Yuan, Jianda, Zaretsky, Jesse M, Desrichard, Alexis, Walsh, Logan A, Postow, Michael A, Wong, Phillip, Ho, Teresa S, Hollmann, Travis J, Bruggeman, Cameron, Kannan, Kasthuri, Li, Yanyun, Elipenahli, Ceyhan, Liu, Cailian, Harbison, Christopher T, Wang, Lisu, Ribas, Antoni, Wolchok, Jedd D, Chan, Timothy A

Volltext

Nivolumab alone and nivolumab plus ipilimumab in recurrent small-cell lung cancer (CheckMate 032): a multicentre, open-label, phase 1/2 trial von Antonia, Scott J, Prof, López-Martin, José A, MD, Bendell, Johanna, MD, Ott, Patrick A, MD, Taylor, Matthew, MD, Eder, Joseph Paul, MD, Jäger, Dirk, MD, Pietanza, M Catherine, MD, Le, Dung T, MD, de Braud, Filippo, Prof, Morse, Michael A, Prof, Ascierto, Paolo A, MD, Horn, Leora, MD, Amin, Asim, MD, Pillai, Rathi N, MD, Evans, Jeffry, Prof, Chau, Ian, MD, Bono, Petri, MD, Atmaca, Akin, MD, Sharma, Padmanee, Prof, Harbison, Christopher T, PhD, Lin, Chen-Sheng, PhD, Christensen, Olaf, MD, Calvo, Emiliano, Dr

Volltext

Expression of Epiregulin and Amphiregulin and K-ras Mutation Status Predict Disease Control in Metastatic Colorectal Cancer Patients Treated With Cetuximab von KHAMBATA-FORD, Shirin, GARRETT, Christopher R, TAN, Benjamin R, KRISHNAMURTHI, Smitha S, BURRIS, Howard A, POPLIN, Elizabeth A, HIDALGO, Manuel, BASELGA, Jose, CLARK, Edwin A, MAURO, David J, MEROPOL, Neal, BASIK, Mark, HARBISON, Christopher T, SHUJIAN WU, WONG, Tai W, XIN HUANG, TAKIMOTO, Chris H, GODWIN, Andrew K

Volltext

Analysis of Potential Predictive Markers of Cetuximab Benefit in BMS099, a Phase III Study of Cetuximab and First-Line Taxane/Carboplatin in Advanced Non–Small-Cell Lung Cancer von KHAMBATA-FORD, Shirin, HARBISON, Christopher T, HART, Lowell L, AWAD, Melissa, XU, Li-An, HORAK, Christine E, DAKHIL, Shaker, HERMANN, Robert C, LYNCH, Thomas J, WEBER, Martin R

Volltext

Genome-wide Map of Nucleosome Acetylation and Methylation in Yeast von Pokholok, Dmitry K., Harbison, Christopher T., Levine, Stuart, Cole, Megan, Hannett, Nancy M., Lee, Tong Ihn, Bell, George W., Walker, Kimberly, Rolfe, P. Alex, Herbolsheimer, Elizabeth, Zeitlinger, Julia, Lewitter, Fran, Gifford, David K., Young, Richard A.

Volltext

Remodeling of yeast genome expression in response to environmental changes von Causton, H C, Ren, B, Koh, S S, Harbison, C T, Kanin, E, Jennings, E G, Lee, T I, True, H L, Lander, E S, Young, R A

Volltext

CheckMate-032 Study: Efficacy and Safety of Nivolumab and Nivolumab Plus Ipilimumab in Patients With Metastatic Esophagogastric Cancer von Janjigian, Yelena Y, Bendell, Johanna, Calvo, Emiliano, Kim, Joseph W, Ascierto, Paolo A, Sharma, Padmanee, Ott, Patrick A, Peltola, Katriina, Jaeger, Dirk, Evans, Jeffry, de Braud, Filippo, Chau, Ian, Harbison, Christopher T, Dorange, Cecile, Tschaika, Marina, Le, Dung T

Volltext

Serial Regulation of Transcriptional Regulators in the Yeast Cell Cycle von Simon, Itamar, Barnett, John, Hannett, Nancy, Harbison, Christopher T, Rinaldi, Nicola J, Volkert, Thomas L, Wyrick, John J, Zeitlinger, Julia, Gifford, David K, Jaakkola, Tommi S, Young, Richard A

Volltext

Nivolumab with or without ipilimumab in patients with recurrent glioblastoma: results from exploratory phase I cohorts of CheckMate 143 von Omuro, Antonio, Vlahovic, Gordana, Lim, Michael, Sahebjam, Solmaz, Baehring, Joachim, Cloughesy, Timothy, Voloschin, Alfredo, Ramkissoon, Shakti H, Ligon, Keith L, Latek, Robert, Zwirtes, Ricardo, Strauss, Lewis, Paliwal, Prashni, Harbison, Christopher T, Reardon, David A, Sampson, John H

Volltext

Nivolumab versus Docetaxel in Advanced Squamous-Cell Non–Small-Cell Lung Cancer von Brahmer, Julie, Reckamp, Karen L, Baas, Paul, Crinò, Lucio, Eberhardt, Wilfried E.E, Poddubskaya, Elena, Antonia, Scott, Pluzanski, Adam, Vokes, Everett E, Holgado, Esther, Waterhouse, David, Ready, Neal, Gainor, Justin, Arén Frontera, Osvaldo, Havel, Libor, Steins, Martin, Garassino, Marina C, Aerts, Joachim G, Domine, Manuel, Paz-Ares, Luis, Reck, Martin, Baudelet, Christine, Harbison, Christopher T, Lestini, Brian, Spigel, David R

Volltext

Nivolumab in Combination With Platinum-Based Doublet Chemotherapy for First-Line Treatment of Advanced Non-Small-Cell Lung Cancer von Rizvi, Naiyer A, Hellmann, Matthew D, Brahmer, Julie R, Juergens, Rosalyn A, Borghaei, Hossein, Gettinger, Scott, Chow, Laura Q, Gerber, David E, Laurie, Scott A, Goldman, Jonathan W, Shepherd, Frances A, Chen, Allen C, Shen, Yun, Nathan, Faith E, Harbison, Christopher T, Antonia, Scott

Volltext

Nivolumab versus Docetaxel in Advanced Nonsquamous Non–Small-Cell Lung Cancer von Borghaei, Hossein, Paz-Ares, Luis, Horn, Leora, Spigel, David R, Steins, Martin, Ready, Neal E, Chow, Laura Q, Vokes, Everett E, Felip, Enriqueta, Holgado, Esther, Barlesi, Fabrice, Kohlhäufl, Martin, Arrieta, Oscar, Burgio, Marco Angelo, Fayette, Jérôme, Lena, Hervé, Poddubskaya, Elena, Gerber, David E, Gettinger, Scott N, Rudin, Charles M, Rizvi, Naiyer, Crinò, Lucio, Blumenschein, George R, Antonia, Scott J, Dorange, Cécile, Harbison, Christopher T, Graf Finckenstein, Friedrich, Brahmer, Julie R

Volltext

Program-Specific Distribution of a Transcription Factor Dependent on Partner Transcription Factor and MAPK Signaling von Zeitlinger, Julia, Simon, Itamar, Harbison, Christopher T., Hannett, Nancy M., Volkert, Thomas L., Fink, Gerald R., Young, Richard A.

Volltext

Activity and safety of nivolumab, an anti-PD-1 immune checkpoint inhibitor, for patients with advanced, refractory squamous non-small-cell lung cancer (CheckMate 063): a phase 2, s... von Rizvi, Naiyer A, Dr, Mazières, Julien, Prof, Planchard, David, MD, Stinchcombe, Thomas E, MD, Dy, Grace K, MD, Antonia, Scott J, MD, Horn, Leora, MD, Lena, Hervé, MD, Minenza, Elisa, MD, Mennecier, Bertrand, MD, Otterson, Gregory A, MD, Campos, Luis T, MD, Gandara, David R, MD, Levy, Benjamin P, MD, Nair, Suresh G, MD, Zalcman, Gérard, Prof, Wolf, Jürgen, Prof, Souquet, Pierre-Jean, MD, Baldini, Editta, MD, Cappuzzo, Federico, MD, Chouaid, Christos, MD, Dowlati, Afshin, MD, Sanborn, Rachel, MD, Lopez-Chavez, Ariel, MD, Grohe, Christian, Prof, Huber, Rudolf M, Prof, Harbison, Christopher T, PhD, Baudelet, Christine, PhD, Lestini, Brian J, MD, Ramalingam, Suresh S, Prof

Volltext

Reconstructing dynamic regulatory maps von Ernst, Jason, Vainas, Oded, Harbison, Christopher T, Simon, Itamar, Bar‐Joseph, Ziv

Volltext

Transcriptional regulatory code of a eukaryotic genome von Harbison, C.T, Gordon, D.B, Lee, T.I, Rinaldi, N.J, Macisaac, K.D, Danford, T.W, Hannett, N.M, Tagne, J.B, Reynolds, D.B, Yoo, J

Volltext

Transcriptional Regulatory Networks in Saccharomyces cerevisiae von Lee, Tong Ihn, Rinaldi, Nicola J., Robert, François, Odom, Duncan T., Bar-Joseph, Ziv, Gerber, Georg K., Hannett, Nancy M., Harbison, Christopher T., Thompson, Craig M., Simon, Itamar, Zeitlinger, Julia, Jennings, Ezra G., Murray, Heather L., Gordon, D. Benjamin, Ren, Bing, Wyrick, John J., Tagne, Jean-Bosco, Volkert, Thomas L., Fraenkel, Ernest, Gifford, David K., Young, Richard A.

Volltext

Phase I–IIa study of BMS-690514, an EGFR, HER-2 and -4 and VEGFR-1 to -3 oral tyrosine kinase inhibitor, in patients with advanced or metastatic solid tumours von Soria, Jean-Charles, Baselga, José, Hanna, Nasser, Laurie, Scott A, Bahleda, Rastislav, Felip, Enriqueta, Calvo, Emiliano, Armand, Jean-Pierre, Shepherd, Frances A, Harbison, Christopher T, Berman, David, Park, Jong-Soon, Zhang, Steven, Vakkalagadda, Blisse, Kurland, John F, Pathak, Ashutosh K, Herbst, Roy S

Volltext

Validation of companion diagnostic for detection of mutations in codons 12 and 13 of the KRAS gene in patients with metastatic colorectal cancer: analysis of the NCIC CTG CO.17 tri... von Harbison, Christopher T, Horak, Christine E, Ledeine, Jean-Marie, Mukhopadhyay, Pralay, Malone, Daniel P, O'Callaghan, Chris, Jonker, Derek J, Karapetis, Christos S, Khambata-Ford, Shirin, Gustafson, Nancy, Trifan, Ovidiu C, Chang, Shao-Chun, Ravetto, Paul, Iv, George A Green

Volltext